CFTR and cystic fibrosis: In patients with CF, their immune system has been tolerized toward the mutated form of CFTR [164], therefore, effective delivery and translation of wild-type CFTR in these patients may result in the presentation of peptides which could result in T cell activation towards transfected epithelial cells.